CD34 and cardiovascular disorder: Better understanding of FKN/CX3CR1 dependent mechanisms that render CD34+ progenitor cells immunogenic may be of interest to favor stem cell mediated regeneration in various diseases and may contribute to design therapies interfering with the FKN-CX3CR1 pathway to improve graft survival and limit cardiovascular disorders.